Microbix Biosystems Valuation
| MBX Stock | CAD 0.31 0.01 3.13% |
Microbix Biosystems seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Microbix Biosystems from analyzing the firm fundamentals such as Current Valuation of 35.24 M, return on equity of 0.2, and Profit Margin of 0.22 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Microbix Biosystems' valuation include:
Price Book 1.4879 | Enterprise Value 35.2 M | Enterprise Value Ebitda 4.6882 | Price Sales 1.8138 | Forward PE 15.2439 |
Overvalued
Today
Please note that Microbix Biosystems' price fluctuation is abnormally volatile at this time. Calculation of the real value of Microbix Biosystems is based on 3 months time horizon. Increasing Microbix Biosystems' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Microbix Biosystems is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Microbix Stock. However, Microbix Biosystems' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.31 | Real 0.27 | Hype 0.31 | Naive 0.31 |
The intrinsic value of Microbix Biosystems' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Microbix Biosystems' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Microbix Biosystems helps investors to forecast how Microbix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Microbix Biosystems more accurately as focusing exclusively on Microbix Biosystems' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Microbix Biosystems' intrinsic value based on its ongoing forecasts of Microbix Biosystems' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Microbix Biosystems' closest peers.
Microbix Biosystems Cash |
|
Microbix Valuation Trend
Knowing Microbix Biosystems' actual value is paramount for traders when making sound investment determinations. Using both Microbix Biosystems' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Microbix Biosystems Total Value Analysis
Microbix Biosystems is now anticipated to have takeover price of 35.24 M with market capitalization of 42.38 M, debt of 6.65 M, and cash on hands of 402.12 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Microbix Biosystems fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.24 M | 42.38 M | 6.65 M | 402.12 K |
Microbix Biosystems Investor Information
About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Microbix Biosystems last dividend was issued on the 2nd of September 1999. Based on the key indicators related to Microbix Biosystems' liquidity, profitability, solvency, and operating efficiency, Microbix Biosystems is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Microbix Biosystems Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Microbix Biosystems has an asset utilization ratio of 46.32 percent. This suggests that the Company is making C$0.46 for each dollar of assets. An increasing asset utilization means that Microbix Biosystems is more efficient with each dollar of assets it utilizes for everyday operations.Microbix Biosystems Ownership Allocation
Microbix Biosystems maintains a total of 136.7 Million outstanding shares. Microbix Biosystems secures 14.18 % of its outstanding shares held by insiders and 0.43 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Microbix Biosystems Profitability Analysis
The company reported the revenue of 16.51 M. Net Loss for the year was (39.48 K) with profit before overhead, payroll, taxes, and interest of 11.12 M.About Microbix Biosystems Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Microbix Biosystems. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Microbix Biosystems based exclusively on its fundamental and basic technical indicators. By analyzing Microbix Biosystems's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Microbix Biosystems's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Microbix Biosystems. We calculate exposure to Microbix Biosystems's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Microbix Biosystems's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 8.6 M | 4.4 M | |
| Operating Profit Margin | (0.15) | (0.16) | |
| Gross Profit Margin | 0.52 | 0.63 |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.